“Hepatitis+C”的搜索结果，显示 421-430 项，共有 11127 项

1. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

2. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

3. 普通内科- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine whether serum biomarkers and comorbidities differ between subjects with hEDS/HSD vs. other non-hypermobile EDS ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... C) current COG recommended high-risk therapy with the addition of a block of 131I-MIBG after the third Induction cycle and substitution of busulfan ...

5. 头颈癌- 医生与科室- 妙佑医疗国际

   显示$起始范围- $结束范围/源自可用$可用医生. 姓氏首字母: C,C,C,C. William J. Casey, III, M.D.. Plastic Surgeon. Phoenix, AZ. 擅长领域 ...

6. 间质性肺病- 医生与科室- 妙佑医疗国际

   科室与专家门诊. 妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一，在亚利桑那州、佛罗里达州和明尼苏达州都有院区。医务人员掌握数几十种专业技能，齐心协力， ...

7. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This study is being done to store blood, buccal (cheek) cells, genetic material including DNA (deoxyribonucleic acid) and RNA (ribonucleic acid), ...

9. 血液科- 临床试验- 妙佑医疗国际

   This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

10. 血液科- 临床试验- 妙佑医疗国际

    Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...